ABSTRACT
Objective To assess the efficacy of an esophageal device to provide TTM (Target Temperature Management) post Cardiac Arrest
Design A chart review of all patients treated with ETTM, following cardiac arrest. Initial patient temperature, time to target, supplemental methods (water blankets, head wraps, or ice packs), and patient survival were extracted for analysis.
Setting Community Medical Center Intensive Care Unit
Patients All patients receiving TTM via an esophageal device post Cardiac Arrest from August 2016 to November 2018
Interventions TTM both cooling and warming via an esophageal device
Measurements and Results A total of 54 patients were treated from August 2016 to November 2018; 30 received ETM only, 22 received supplemental cooling, and 2 had treatment discontinued prior to reaching target due to recovery. Target temperatures ranged from 32 to 36 degrees. The median time to target temperature for the entire cohort was 219 minutes (IQR 81-415). For the cohorts without, and with, supplemental cooling modalities, the median time to attain target temperature was 128 minutes (IQR 71-334), and 285 minutes (IQR 204-660), respectively. Survival to ICU discharge was 51.9% for the entire cohort.
Conclusions ETM attains target temperature at a rate consistent with current guidelines and with similar performance to alternative modalities. This may provide a more cost-effective and approachable core cooling option to community hospitals that only use water blankets or other surface methods.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This was an IRB approved retrospective study of Critical Care Patients Post Cardiac Arrest managed with an Esophageal Device for TTM
Funding Statement
All funds, other than a $200 data integration fee were part of the regular funding for each participant.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Yes
Footnotes
No reprints are available for this paper,
No external funding was received for this study. All funding was internally provided using hospital resources.
Data Availability
All data used was de-identified and extracted with IRB permission from hospital records. We hold securely that de-identified data.
